Research Excellence Award
Allegheny Health Network ,United States
| David Bartlett | |
|---|---|
| Affiliation | Allegheny Health Network |
| Country | United States |
| Scopus ID | 7202592506 |
| Documents | 491 |
| Citations | 25,291 |
| h-index | 88 |
| Subject Area | Vaccinia Virus |
| Event | International Molecular Biologist Awards |
| ORCID | 0000-0003-3099-2613 |
David Bartlett is recognized for his scholarly contributions in biomedical science and viral oncology research, particularly in areas associated with vaccinia virus studies, immunotherapy, translational medicine, and cancer-related molecular investigations. His publication portfolio and extensive citation record demonstrate sustained engagement in multidisciplinary biomedical research and international scientific collaboration.[1]
Abstract
This article presents an academic overview of David Bartlett and his contributions to biomedical and molecular biological sciences. The profile highlights his research engagement in vaccinia virus studies, translational oncology, immunotherapeutic innovation, and scientific publication activities. Citation metrics, scholarly dissemination, and interdisciplinary collaborations demonstrate measurable scientific influence within molecular medicine and viral oncology research communities.[2]
Keywords
Vaccinia Virus; Molecular Biology; Cancer Immunotherapy; Viral Oncology; Translational Medicine; Biomedical Research; Scientific Publications; Molecular Therapeutics.
Introduction
Vaccinia virus research has played a significant role in the development of oncolytic virotherapy, immunotherapeutic approaches, and advanced molecular treatment strategies. Modern biomedical science increasingly integrates viral vectors, molecular genetics, and translational medicine to improve therapeutic interventions and clinical outcomes.[3]
Researchers involved in this field contribute to scientific progress through publication dissemination, clinical investigations, and collaborative interdisciplinary studies. David Bartlett’s academic activities align with these objectives through extensive publication output and impactful biomedical research participation.[1]
Research Profile
David Bartlett has established a research profile associated with molecular oncology, vaccinia virus applications, immunotherapy, and translational biomedical science. His scholarly output includes numerous peer-reviewed publications indexed in international citation databases, reflecting sustained scientific engagement and broad research visibility.[2]
- Research specialization in vaccinia virus and molecular oncology.
- Extensive publication activity within biomedical sciences.
- Interdisciplinary collaboration involving translational medicine and immunotherapy.
- Citation-indexed scholarly communication and scientific dissemination.
- Academic contributions to viral therapeutics and molecular medicine.
Research Contributions
The scientific contributions of David Bartlett include research associated with viral oncology, cancer immunotherapy, molecular therapeutic strategies, and translational biomedical applications. His work has contributed to the broader scientific understanding of viral vector utilization and therapeutic innovation within clinical and molecular medicine.[4]
- Contribution to vaccinia virus and viral therapeutic research.
- Participation in translational cancer immunotherapy investigations.
- Scientific dissemination through peer-reviewed biomedical publications.
- Collaborative interdisciplinary research within molecular medicine.
Publications
The publication profile of David Bartlett includes a substantial number of indexed scientific articles, reviews, and collaborative biomedical studies. His scholarly output demonstrates long-term research productivity and broad academic engagement within viral oncology and molecular therapeutic sciences.[1]
- 491 indexed scientific documents in international databases.
- Research publications associated with molecular oncology and virotherapy.
- Collaborative biomedical investigations and translational studies.
- High citation visibility across biomedical and molecular research fields.
Research Impact
Research metrics indicate substantial academic visibility and scholarly influence. With more than 25,000 citations and a high h-index, David Bartlett’s work demonstrates significant recognition within biomedical and molecular science communities. These indicators reflect sustained citation dissemination, scientific relevance, and broad research utilization.[2]
His research impact is further supported by collaborative scientific engagement and publication activities associated with translational oncology and viral therapeutics.[3]
Award Suitability
The International Molecular Biologist Awards recognize individuals demonstrating outstanding scientific contributions, publication quality, interdisciplinary collaboration, and measurable research influence within molecular biological sciences. David Bartlett’s publication record, citation metrics, and contributions to vaccinia virus and molecular oncology research align with the objectives of international scientific recognition programs.[5]
His academic profile demonstrates sustained scientific productivity and impactful biomedical research engagement relevant to research excellence distinctions in molecular biology and translational medicine.[4]
Conclusion
David Bartlett has contributed extensively to biomedical science through research associated with vaccinia virus applications, molecular oncology, and translational medicine. His scholarly visibility, citation impact, and interdisciplinary collaborations demonstrate substantial scientific engagement and continued relevance within international molecular biology and biomedical research communities.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: David Bartlett, Author ID 7202592506. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=7202592506 - National Library of Medicine. (2021). Advances in Viral Oncology and Translational Medicine.
https://www.hpbonline.org/article/S1365-182X(24)00048-0/fulltext - Nature Medicine. (2016). Vaccinia virus applications in cancer immunotherapy.
https://doi.org/10.1038/nm.3988 - ORCID. (n.d.). ORCID profile record for David Bartlett.
https://orcid.org/0000-0003-3099-2613 - International Molecular Biologist Awards. (n.d.). Research excellence recognition framework in molecular biological sciences.
https://molecularbiologist.org/
“`